ABIOMED INC (Brazil) Today

A1BM34 -  Brazil Stock  

BRL 399.86  25.60  6.02%

ABIOMED INC is trading at 399.86 as of the 25th of July 2021, a -6.02 percent down since the beginning of the trading day. The stock's open price was 425.46. ABIOMED INC has about a 41 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for ABIOMED INC DRN are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of April 2021 and ending today, the 25th of July 2021. Click here to learn more.
 Market Performance
0 of 100
  Odds Of Distress
Less than 41
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

ABIOMED INC Stock Profile

Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. The company was founded in 1981 and is headquartered in Danvers, Massachusetts. ABIOMED INC operates under Medical Devices classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 1725 people. more on ABIOMED INC
ABIOMED INC DRN generates negative expected return over the last 90 days
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of ABIOMED INC's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong SellOvervalued
ABIOMED INC DRN (A1BM34) is traded on Sao Paolo Stock Exchange in Brazil and employs 1,725 people. The company currently falls under 'Large-Cap' category with current market capitalization of 71.99 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ABIOMED INC's market, we take the total number of its shares issued and multiply it by ABIOMED INC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. ABIOMED INC DRN operates under Healthcare sector and is part of Medical Devices industry. The entity has 181.38 M outstanding shares. ABIOMED INC DRN has accumulated about 583.69 M in cash with 274.58 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 12.89.
Check ABIOMED INC Probability Of Bankruptcy

ABIOMED Stock Price Odds Analysis

What are ABIOMED INC's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of ABIOMED INC jumping above the current price in 90 days from now is about 50.27%. The ABIOMED INC DRN probability density function shows the probability of ABIOMED INC stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon ABIOMED INC has a beta of 0.2057. This suggests as returns on the market go up, ABIOMED INC average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding ABIOMED INC DRN will be expected to be much smaller as well. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. ABIOMED INC DRN is significantly underperforming DOW.
 Odds Down 399.86HorizonTargetOdds Up 399.86 
49.57%90 days
Based on a normal probability distribution, the odds of ABIOMED INC to move above the current price in 90 days from now is about 50.27 (This ABIOMED INC DRN probability density function shows the probability of ABIOMED Stock to fall within a particular range of prices over 90 days) .


Investors will always prefer to have the highest possible return on investment while minimizing volatility. ABIOMED INC market risk premium is the additional return an investor will receive from holding ABIOMED INC long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in ABIOMED INC. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although ABIOMED INC's alpha and beta are two of the key measurements used to evaluate ABIOMED INC's performance over the market, the standard measures of volatility play an important role as well.

ABIOMED Stock Against Markets

Picking the right benchmark for ABIOMED INC stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in ABIOMED INC stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for ABIOMED INC is critical whether you are bullish or bearish towards ABIOMED INC DRN at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in ABIOMED INC without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Financial Widgets Now


Financial Widgets

Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
All  Next Launch Module
Please continue to Trending Equities. Note that the ABIOMED INC DRN information on this page should be used as a complementary analysis to other ABIOMED INC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Tools for ABIOMED Stock

When running ABIOMED INC DRN price analysis, check to measure ABIOMED INC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABIOMED INC is operating at the current time. Most of ABIOMED INC's value examination focuses on studying past and present price action to predict the probability of ABIOMED INC's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ABIOMED INC's price. Additionally, you may evaluate how the addition of ABIOMED INC to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Global Correlations
Find global opportunities by holding instruments from different markets